Literature DB >> 17883935

Comparison of drug abuse in Germany and China.

Ingo Ilja Michels1, Yu-Xia Fang, Dong Zhao, Li-Yan Zhao, Lin Lu.   

Abstract

Drug abuse has a long, but also different history in Germany and China. The Opium War largely influenced the history of China in 19th century; however, China was once recognized as a drug-free nation for 3 decades from the 1950s to the 1980s. Drug abuse has spread quickly since re-emerging as a national problem in China in the late 1980s. The number of registered drug abusers increased from 70 000 in 1990 to more than 1 million by the end of 2005. In past decades, illicit drug trafficking and production have swept most provinces in China, and drug abuse has caused many problems for both abusers and the community. One major drug-related problem is the spread of HIV, which has caused major social and economic damage in China. Germany, the largest developed European country, also faces the drug and addiction problem. Germany has about 150 000 heroin addicts, for whom HIV/AIDS has become a serious threat since the mid 1980s. To control the drug problem, the German Government adopted the pAction Plan on Drugs and Addictionq in 2003; the China Central Government approved a similar regulation in the antidrug campaign in 2005. Germany has experience in reducing drug-related harm. The methadone maintenance treatment (MMT) program has run for more than 20 years and the public has become more tolerant of addicts. In 2003, China began the MMT program for controlling the spread of HIV/AIDS. It is necessary for China to learn from developed countries to acquire success in its antidrug campaign. In this review, we will go over the differences and similarities in drug abuse between Germany and China. The differences are related to history, population and economics, drug policy context, drug laws, HIV/hepatitis C virus infection, the MMT program and so on. These 2 nations have drug abuse problems with different histories and currently use different approaches to handle illicit drug marketing and use. The legal penalties for illicit drug offences reflect the social differences of these 2 nations with respect to the seriousness of particular types of crimes. The characteristics of the MMT program may also influence patterns of drug abuse in these 2 nations and China should improve the MMT program based on the successful model in Europe, the USA, and Australia. We recommend more dialogue and collaboration between Germany and China.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17883935      PMCID: PMC7091797          DOI: 10.1111/j.1745-7254.2007.00633.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  41 in total

Review 1.  Ecstasy: pharmacology and neurotoxicity.

Authors:  Jenny Morton
Journal:  Curr Opin Pharmacol       Date:  2005-02       Impact factor: 5.547

2.  Group psychotherapy for opiate addicts in methadone maintenance treatment--a controlled trial.

Authors:  N Scherbaum; J Kluwig; M Specka; D Krause; B Merget; T Finkbeiner; M Gastpar
Journal:  Eur Addict Res       Date:  2005       Impact factor: 3.015

Review 3.  Recent trends in drug abuse in China.

Authors:  Yu-xia Fang; Yan-bo Wang; Jie Shi; Zhi-min Liu; Lin Lu
Journal:  Acta Pharmacol Sin       Date:  2006-02       Impact factor: 6.150

4.  The solution to narcotic addiction in the People's Republic of China.

Authors:  P Lowinger
Journal:  Am J Drug Alcohol Abuse       Date:  1977       Impact factor: 3.829

Review 5.  Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.

Authors:  Markus Backmund; Jens Reimer; Kirsten Meyer; J Tilman Gerlach; Reinhart Zachoval
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

6.  Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study.

Authors:  Kathleen M Carroll; Samuel A Ball; Charla Nich; Steve Martino; Tami L Frankforter; Christiane Farentinos; Lynn E Kunkel; Susan K Mikulich-Gilbertson; Jon Morgenstern; Jeanne L Obert; Doug Polcin; Ned Snead; George E Woody
Journal:  Drug Alcohol Depend       Date:  2005-09-28       Impact factor: 4.492

Review 7.  [Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].

Authors:  E Gouzoulis-Mayfrank; L Hermle; K A Kovar; H Sass
Journal:  Nervenarzt       Date:  1996-05       Impact factor: 1.214

8.  Use of a low-cost incentive intervention to improve counseling attendance among methadone-maintained patients.

Authors:  Stacey C Sigmon; Maxine L Stitzer
Journal:  J Subst Abuse Treat       Date:  2005-12

9.  Acceptability and availability of pharmacological interventions for substance misuse by British NHS treatment services.

Authors:  Harold Rosenberg; John Melville; P C McLean
Journal:  Addiction       Date:  2002-01       Impact factor: 6.526

Review 10.  Prevention and control of hepatitis B in China.

Authors:  Zongtang Sun; Lihua Ming; Xu Zhu; Jianhua Lu
Journal:  J Med Virol       Date:  2002-07       Impact factor: 2.327

View more
  4 in total

Review 1.  Drug abuse in China: past, present and future.

Authors:  Lin Lu; Yuxia Fang; Xi Wang
Journal:  Cell Mol Neurobiol       Date:  2007-11-08       Impact factor: 5.046

2.  Effects of cannabinoid CB1 receptor antagonist rimonabant in consolidation and reconsolidation of methamphetamine reward memory in mice.

Authors:  Lu-lu Yu; Xue-yi Wang; Mei Zhao; Yu Liu; Yan-qin Li; Fang-qiong Li; Xiaoyi Wang; Yan-xue Xue; Lin Lu
Journal:  Psychopharmacology (Berl)       Date:  2009-01-16       Impact factor: 4.530

3.  [Burden of disease and level of patient's medical care in substitution treatment for opiates].

Authors:  Matthias C Müller; Matthias Pichler; Gabi Martin; Diana Plörer; Catja Winter; Oliver Pogarell; Johannes R Bogner
Journal:  Med Klin (Munich)       Date:  2009-12-30

4.  Patterns of childhood trauma and psychological distress among injecting heroin users in China.

Authors:  Zhen Wang; Jiang Du; Haiming Sun; Helen Wu; Zeping Xiao; Min Zhao
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.